Philip F. Palmedo
2022
In 2022, Philip F. Palmedo earned a total compensation of $84.5K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 81% decrease compared to previous year.
Compensation breakdown
| Option Awards | $63,340 |
|---|---|
| Other | $21,148 |
| Total | $84,488 |
Palmedo received $63.3K in option awards, accounting for 75% of the total pay in 2022.
Palmedo also received $21.1K in other compensation.
Rankings
In 2022, Philip F. Palmedo's compensation ranked 5,626th out of 5,756 executives tracked by ExecPay. In other words, Palmedo earned more than 2.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,626 out of 5,756 | 2nd |
Division Manufacturing | 3,068 out of 3,133 | 2nd |
Major group Chemicals And Allied Products | 1,394 out of 1,419 | 2nd |
Industry group Drugs | 1,301 out of 1,320 | 1st |
Industry Pharmaceutical Preparations | 950 out of 966 | 2nd |
Source: SEC filing on November 4, 2024.
Palmedo's colleagues
We found six more compensation records of executives who worked with Philip F. Palmedo at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
Bas der Baan
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
René Bernards
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Yun Yen
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Regina Brown
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Stephen Forman
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Gil Schwartzberg
LIXTE BIOTECHNOLOGY HOLDINGS